Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex.Market expands logistics network

4/11/25 YDEX

VK disclosed the buyers of the additional share issue

4/11/25 VKCO

Sollers sales in Q1 2025 declined by 5%

4/11/25 SVAV

Board of Directors of Territorial Generating Company № 14 recommended that dividends be paid for 2024

4/11/25 TGKN

X5 started construction of its own DPC in the Moscow region

4/10/25 FIVE

OGK-2's power generation in Q1 decreased by 3.6%

4/10/25 OGKB

Board of Directors of Tatneft recommended that dividends be paid for 2024

4/10/25 TATN

RusHydro completed modernization of Volzhskaya HPP

4/10/25 HYDR

M.Video-Eldorado presented key vectors of the strategy for 2025-2027

4/10/25 MVID

Henderson reported for January through March 2025

4/10/25 HNFG